GITNUXREPORT 2025

Clinical Trial Recruitment Statistics

Effective recruitment strategies reduce delays, costs, and improve trial diversity significantly.

Jannik Linder

Co-Founder of Gitnux, specialized in content and tech since 2016.

First published: April 29, 2025

Our Commitment to Accuracy

Rigorous fact-checking • Reputable sources • Regular updatesLearn more

Statistic 1

The average cost of recruiting a single participant in a clinical trial is approximately $4,000

Statistic 2

Clinical trial recruitment difficulties cost the industry an estimated $600 million annually in delays and additional staffing

Statistic 3

Only about 3-5% of American patients with cancer participate in clinical trials

Statistic 4

Patients are more likely to enroll in trials if they are informed about the trial through their primary care physician

Statistic 5

Nearly 40% of patients consider participation in clinical trials as a way to access new treatments

Statistic 6

Community engagement increases trial recruitment success rates by approximately 20%

Statistic 7

Diversity in clinical trial enrollment is often below 10% for minority populations, impacting generalizability

Statistic 8

Only around 50% of eligible patients consent to participate once approached, highlighting consent barriers

Statistic 9

Trial participants who are actively recruited via digital platforms have a 35% higher retention rate than those recruited through traditional methods

Statistic 10

About 30% of patients eligible for clinical trials are unaware of their eligibility due to lack of information

Statistic 11

Enrollment rates are particularly low among minority and rural populations, contributing to trial underrepresentation

Statistic 12

The use of patient portals has contributed to a 15% increase in recruitment rates, by providing easier access to trial information

Statistic 13

The retention of minority participants is often less than 50%, impacting the diversity and applicability of results

Statistic 14

Trial recruitment success correlates with the use of culturally tailored messaging, with a reported increase of up to 30% in enrollment rates

Statistic 15

Approximately 80% of clinical trials face delays due to recruitment issues

Statistic 16

The average recruitment period for phase III trials is around 12-14 months

Statistic 17

Nearly 70% of clinical trial sites fail to enroll their projected enrollment targets

Statistic 18

Around 60% of trials are delayed due to recruitment challenges

Statistic 19

Less than 20% of clinical trials manage to recruit their target sample size within the planned timeline

Statistic 20

45% of clinical trial participants drop out before completion, often due to recruitment difficulties

Statistic 21

Nearly 50% of clinical study sites report difficulty in finding eligible patients

Statistic 22

Recruitment issues contribute to approximately 37% of trial delays

Statistic 23

The average age of clinical trial participants is around 45 years old, but many diseases primarily affect older adults, which complicates recruitment

Statistic 24

25% of clinical trials are terminated early, often due to slow recruitment

Statistic 25

Approximately 65% of trials do not meet recruitment targets within the planned timeline, leading to increased costs and delays

Statistic 26

Recruiting patients for rare disease trials is about 10 times more challenging than for common conditions, due to small patient populations

Statistic 27

The median recruitment duration for oncology trials is approximately 18 months, often longer than planned

Statistic 28

Over 40% of clinical trials fail due to insufficient patient recruitment, underscoring its critical role in trial success

Statistic 29

Trial sponsors that implement decentralized trial models report 15-20% faster recruitment, compared to traditional site-based models

Statistic 30

Fit-to-participate assessments help increase eligibility and recruitment efficiency by up to 25%, according to recent research

Statistic 31

The probability of successful recruitment increases by 40% when a dedicated recruitment team is employed, compared to trials without one

Statistic 32

Nearly 70% of clinical trials in the US experience delays due to recruitment or retention issues, leading to increased costs and extended timelines

Statistic 33

A significant proportion of trial delays—up to 50%—are linked directly to recruitment challenges, highlighting the importance of effective strategies

Statistic 34

The overall patient recruitment rate in phase I trials is approximately 12%, much lower compared to later phase trials, due to eligibility and awareness barriers

Statistic 35

Electronic health records (EHRs) are being used in over 50% of patient recruitment strategies

Statistic 36

Virtual recruitment methods increased patient enrollment rates by 25% during the COVID-19 pandemic

Statistic 37

Mobile health technologies improve recruitment efficiency by 30%, according to recent studies

Statistic 38

Artificial intelligence is being used to optimize recruitment strategies in about 15% of trials, improving participant matching

Statistic 39

The use of social media for participant recruitment has increased by over 50% in the last five years

Statistic 40

Approximately 85% of clinical trial sites employ patient registries to aid recruitment

Statistic 41

The integration of telemedicine has led to a 20% increase in recruitment rates in certain trials, especially during the pandemic

Statistic 42

In the last decade, digital recruitment strategies have grown by over 200%, indicating a rapid shift towards online patient engagement

Statistic 43

The use of predictive analytics in recruitment planning has improved patient matching accuracy by 15-25%, according to recent studies

Slide 1 of 43

Sources

Our Reports have been cited by:

Trust Badges - Publications that have cited our reports

Key Highlights

Approximately 80% of clinical trials face delays due to recruitment issues
The average recruitment period for phase III trials is around 12-14 months
Nearly 70% of clinical trial sites fail to enroll their projected enrollment targets
Only about 3-5% of American patients with cancer participate in clinical trials
Around 60% of trials are delayed due to recruitment challenges
Electronic health records (EHRs) are being used in over 50% of patient recruitment strategies
Virtual recruitment methods increased patient enrollment rates by 25% during the COVID-19 pandemic
Less than 20% of clinical trials manage to recruit their target sample size within the planned timeline
The average cost of recruiting a single participant in a clinical trial is approximately $4,000
45% of clinical trial participants drop out before completion, often due to recruitment difficulties
Patients are more likely to enroll in trials if they are informed about the trial through their primary care physician
Nearly 50% of clinical study sites report difficulty in finding eligible patients
Recruitment issues contribute to approximately 37% of trial delays

Did you know that nearly 70% of clinical trials face delays primarily due to recruitment challenges, costing the industry billions and prompting innovative solutions like digital strategies, AI, and community engagement to turn the tide?

Cost and Economic Impact

The average cost of recruiting a single participant in a clinical trial is approximately $4,000
Clinical trial recruitment difficulties cost the industry an estimated $600 million annually in delays and additional staffing

Cost and Economic Impact Interpretation

With each participant costing around $4,000 and recruitment hurdles draining nearly $600 million annually in delays and staffing, the industry is essentially paying a hefty price tag for the challenge of finding the right people—highlighting that, sometimes, recruiting costs more than the trial itself.

Patient Engagement and Diversity

Only about 3-5% of American patients with cancer participate in clinical trials
Patients are more likely to enroll in trials if they are informed about the trial through their primary care physician
Nearly 40% of patients consider participation in clinical trials as a way to access new treatments
Community engagement increases trial recruitment success rates by approximately 20%
Diversity in clinical trial enrollment is often below 10% for minority populations, impacting generalizability
Only around 50% of eligible patients consent to participate once approached, highlighting consent barriers
Trial participants who are actively recruited via digital platforms have a 35% higher retention rate than those recruited through traditional methods
About 30% of patients eligible for clinical trials are unaware of their eligibility due to lack of information
Enrollment rates are particularly low among minority and rural populations, contributing to trial underrepresentation
The use of patient portals has contributed to a 15% increase in recruitment rates, by providing easier access to trial information
The retention of minority participants is often less than 50%, impacting the diversity and applicability of results
Trial recruitment success correlates with the use of culturally tailored messaging, with a reported increase of up to 30% in enrollment rates

Patient Engagement and Diversity Interpretation

Despite only 3-5% of cancer patients participating in trials, leveraging primary care physicians, digital outreach, and culturally tailored messages could nearly double enrollment, yet persistent gaps in awareness and diversity threaten the validity and equity of clinical research.

Recruitment Challenges and Delays

Approximately 80% of clinical trials face delays due to recruitment issues
The average recruitment period for phase III trials is around 12-14 months
Nearly 70% of clinical trial sites fail to enroll their projected enrollment targets
Around 60% of trials are delayed due to recruitment challenges
Less than 20% of clinical trials manage to recruit their target sample size within the planned timeline
45% of clinical trial participants drop out before completion, often due to recruitment difficulties
Nearly 50% of clinical study sites report difficulty in finding eligible patients
Recruitment issues contribute to approximately 37% of trial delays
The average age of clinical trial participants is around 45 years old, but many diseases primarily affect older adults, which complicates recruitment
25% of clinical trials are terminated early, often due to slow recruitment
Approximately 65% of trials do not meet recruitment targets within the planned timeline, leading to increased costs and delays
Recruiting patients for rare disease trials is about 10 times more challenging than for common conditions, due to small patient populations
The median recruitment duration for oncology trials is approximately 18 months, often longer than planned
Over 40% of clinical trials fail due to insufficient patient recruitment, underscoring its critical role in trial success
Trial sponsors that implement decentralized trial models report 15-20% faster recruitment, compared to traditional site-based models
Fit-to-participate assessments help increase eligibility and recruitment efficiency by up to 25%, according to recent research
The probability of successful recruitment increases by 40% when a dedicated recruitment team is employed, compared to trials without one
Nearly 70% of clinical trials in the US experience delays due to recruitment or retention issues, leading to increased costs and extended timelines
A significant proportion of trial delays—up to 50%—are linked directly to recruitment challenges, highlighting the importance of effective strategies
The overall patient recruitment rate in phase I trials is approximately 12%, much lower compared to later phase trials, due to eligibility and awareness barriers

Recruitment Challenges and Delays Interpretation

With nearly 80% of clinical trials battling recruitment delays—often stemming from eligibility issues, patient awareness, and disease rarity—it's clear that no matter how groundbreaking the science, the real challenge lies in filling the seats before the spotlight can shine.

Technologies and Innovations in Recruitment

Electronic health records (EHRs) are being used in over 50% of patient recruitment strategies
Virtual recruitment methods increased patient enrollment rates by 25% during the COVID-19 pandemic
Mobile health technologies improve recruitment efficiency by 30%, according to recent studies
Artificial intelligence is being used to optimize recruitment strategies in about 15% of trials, improving participant matching
The use of social media for participant recruitment has increased by over 50% in the last five years
Approximately 85% of clinical trial sites employ patient registries to aid recruitment
The integration of telemedicine has led to a 20% increase in recruitment rates in certain trials, especially during the pandemic
In the last decade, digital recruitment strategies have grown by over 200%, indicating a rapid shift towards online patient engagement
The use of predictive analytics in recruitment planning has improved patient matching accuracy by 15-25%, according to recent studies

Technologies and Innovations in Recruitment Interpretation

As digital innovations—from EHRs to AI and social media—rapidly reshape clinical trial recruitment, they not only boost efficiency and diversity but also underscore that in the race to enroll participants, technology is steering the pace of discovery itself.